Pure red cell aplasia with the onset of graft versus host disease

Bone Marrow Transplantation

Volumn 32, Issue 11, 2003, Pages 1099-1101

  Grigg, Andrew P ^a   Juneja, S K ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

GVHD; Pure red cell aplasia

Indexed keywords

CYANOCOBALAMIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ERYTHROPOIETIN; FERRITIN; FLUDARABINE; FOLIC ACID; METHOTREXATE; PREDNISOLONE; STEROID; T LYMPHOCYTE RECEPTOR; TAUROURSODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID;

ADULT; ALLOTRANSPLANTATION; ARTICLE; BLOOD COMPATIBILITY; BLOOD GROUP ABO SYSTEM; CASE REPORT; CHRONIC GRAFT REJECTION; DRUG WITHDRAWAL; ERYTHROPOIESIS; GENE REARRANGEMENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOLECULAR CLONING; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PURE RED CELL ANEMIA;

ABO BLOOD-GROUP SYSTEM; GENES, T-CELL RECEPTOR GAMMA; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSION; MALE; MIDDLE AGED; RED-CELL APLASIA, PURE;

EID: 0346752215     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704271     Document Type: Article

References (11)

1. Dessypris EN. Pure red cell aplasia. In Hoffman R, Bonn EJ, Senthil SJ (eds) Hematology. Basic Principles and Practice. 3rd edition, Churchill Livingstone: New York, pp 342-354.
2. Bolan CD, Leitman SF, Griffith LM et al. Delayed donor red cell chimerism and pure red cell aplasia following major-ABO incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood 2001; 98: 1687-1694.
3. Sherery, Shoenfeld Y. Auto-immune disease and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant 1998; 22: 873-881.
4. Godder K, Pati AR, Abhyankar SH et al. De novo chronic graft-versus-host disease presenting as hemolytic anemia following partially mismatched related donor bone marrow transplant. Bone Marrow Transplant 1997; 19: 813-817.
5. Graze PR, Gale PR. Chronic graft versus host disease: a syndrome of disordered immunity. Am J Med 1979; 66: 611-620.
6. Hsu JW, Czader M, Anders V et al. Parvovirus B19-associated pure red cell aplasia in chronic graft-versus-host disease. Br J Haematol 2002; 119: 268-288.
7. Casadevall N, Dupuy E, Molho-Sabatier P et al. Autoantibodies against erythropoietin in a patient with pure red-cell aplasia. New Engl J Med 1996; 334: 630-633.
8. Charles RJ, Sabo KM, Kidd PG, Abkowitz JL. The pathophysiology of pure red cell aplasia: implications for therapy. Blood 1996; 87: 4831-4838.
9. Dincol, G, Aktan M, Nalcaci M et al. Clonality of acquired primary pure red cell aplasia: effectiveness of antithymocyte globulin. Leuk Lymphoma 2001; 42: 1413-1417.
10. Masuko K, Kato S, Hagihara M et al. Stable clonal expansion of T cells induced by bone marrow transplantation. Blood 1996; 87: 789-799.
11. Leino L, Lilius EM, Nikoskelainen J et al. The reappearance of 10 differentiation antigens on peripheral blood lymphocytes after allogeneic bone marrow transplantation. Bone Marrow Transplant 1991; 8: 339-344.